Business Wire

GWI Launches New Office in Singapore, Expands APAC Footprint

17.8.2021 08:28:00 EEST | Business Wire | Press release

Share

GWI, the leading target audience company, today announces the opening of its first APAC office this October in Singapore.

Currently headquartered in London with offices in New York, Prague and Athens, the new Singapore office will position GWI as leading providers of world class research capabilities and solid insights to companies in the APAC region.

Tom Smith, CEO and Founder of GWI explains: “We are powering a world where every business knows its audience. We need to build our presence on the ground in the Asia Pacific to take advantage of the region’s rapidly growing business opportunities. APAC currently represents 20% of our accounts, worth £1.275bn, and has the largest compound annual growth rate (CAGR). Since 2017, APAC has experienced the fastest growth of any region with CAGR in excess of 35%.

“What’s more, our own data* tells us that 71% of professionals in APAC agree that being able to adapt quickly is critical to their company’s long term success. Over a third (34%) of decision-makers in APAC say that keeping up with the latest trends is one of their main considerations for bringing in a new product or service. So we know the businesses in the region are in need of fresh data to help them make critical decisions, and by setting up an office in the region we can enable them to focus on what matters, find the best ideas and then make them happen.

“What’s more, over a third (37%)* of professionals in APAC say that understanding their customer or client audience is one of the biggest challenges their company faces, making it their fourth biggest challenge out of a list of about 25 challenges. This really highlights the need for robust, reliable consumer data. Interestingly, this is highest among business professionals in India and Singapore. Creating a presence on the ground will therefore help us to stay ahead of the ever-changing needs of our customers operating in the region.”

Singapore is well positioned to act as a launchpad for high growth, low penetration markets such as China, Japan and Australia. GWI already works extensively with businesses in the APAC region, especially New Zealand and Australia.

Tom continues: “Significantly, we are increasingly asked for local support by some of our biggest clients, from independent agencies to corporate brands. We therefore decided this is the perfect time to expand our company and open an office in Singapore. By putting a team in Singapore, we will be able to overcome any language, cultural, network and timezone challenges whilst accelerating APAC growth.”

The APAC office will initially be staffed by a combination of relocated European team members and locally sourced talent. The open job positions can be viewed here. The expansion into APAC will allow GWI to realise continued growth in the years to come following its successes in 2020 where the company signed over 200 new enterprise customers and posted more than 40% growth in annual recurring revenue.

ENDS

Notes to editors

*Source: Q2 2020 Wave of GWI Work data

About GWI

GWI is the leading supplier of target audience insight to the global marketing industry.

Trusted by the world’s biggest brands, media organizations, and agencies on a daily basis to get closer to their audiences, the company’s flagship survey represents over 2 billion people globally. Using the subscription-based platform, clients like Twitter, Google, Spotify, WPP, IPG, and Omnicom Group gather in-depth insights into behaviors, attitudes, and interests in seconds through a combination of survey data and analytics.

Among a range of leading data products available alongside its flagship survey are:

- GWI USA is a deep dive into the habits, behaviors and attitudes of 240m internet users in the USA.

- GWI Gaming delves into the actions and attitudes of gamers across 15 markets.

- GWI Sports investigates sports fandom and participation across 15 markets.

- GWI Kids gets to the heart of how kids actually think, so you can be sure to kid-proof your ideas and concepts from here on.

- GWI Work gives a detailed view of the lives of business professionals across 10 markets.

- GWI Zeitgeist, included with our core survey, is fielded monthly and zeroes in on the stuff that matters. It’s topical, timely, and relevant.

Those looking for even more bespoke research solutions can enrich GWI data with a range of services like hyper-targeted custom surveys, brand trackers, and recontact studies.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press:
Liam Rawson
Hotwire Global
gwi@hotwireglobal.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 17:25:00 EEST | Press release

Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 14:00:00 EEST | Press release

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye